Explore
Algorithms
Made By
Our Partners
Imaging Biometrics provides AI algorithms for MR imaging in various clinical specialties, including brain.
Riverain Technologies is dedicated to thoracic imaging, providing software tools to aid clinicians in the detection of lung disease.
Cercare Perfusion is a fully-automated, patient-specific perfusion application for brain CT and MRI that provides deep insight into brain tissue oxygenation through standard and unique perfusion biomarkers.
cMRI goes beyond MRI quantification to provide automated, objective quantification, lesion assessment and biomarker-based diagnostic support for dementia, Multiple Sclerosis, Traumatic Brain Injury and Epilepsy.
ClariPi's AI solutions, including ClariCT.AI, ClariPulmo, and ClariSIGMAM, aim to dramatically improve the image noise reduction capabilities, the identification of lung abnormalities, and assessment of breast tissue density, respectively.
Lucida Medical's AI-machine learning software, Pi™, is designed to help radiologists identify prostate cancer lesions from MRI, enabling faster and more accurate prostate cancer detection.
Avicenna.AI's advanced medical imaging AI solutions identify time-sensitive pathologies in CT scans, enhancing clinicians' workflow.
Optellum's Virtual Nodule Clinic solution, the first FDA, CE-MDR-cleared, and reimbursable clinical decision support for early-stage lung cancer, assists clinicians in identifying and tracking at-risk patients, and prioritizing those at highest risk for follow-up interventions.
MiradaXD, Mirada Medical's innovative multi-modality nuclear medicine imaging software, addresses a range of cancer-related challenges, and supports providers with comprehensive oncology imaging solutions.
FEops HEARTguide™, cloud-based structural heart procedure planning platform, provides simulation and AI-based anatomical measurements to help make transcatheter structural heart interventions more predictable for physicians.
SmartSoft Healthcare's CoLumbo, an AI driven solution, offers an image post-processing, which is a non-invasive way of analyzing spinal images. It helps radiologists reduce the reading and reporting time, minimizes errors of omission, and brings standardization in reporting practices.
The groundbreaking BoneView by GLEAMER, certified by CE and FDA, utilizes AI for precise bone fracture identification. Meanwhile, ChestView (CE) aids in spotting pulmonary nodules, and BoneAge evaluates bone maturity.
Get Started With
These Algorithms
Press & PR
Our Partners In The News
ConcertAI's TeraRecon Adds the Releases of an AI-Assisted Clinical Suite Solution, Neuro Suite to Provide Comprehensive Solutions for Neurological Disorders
by TeraRecon, on Apr 28, 2023 2:00:18 PM
Combinostics Partnership with ConcertAI's TeraRecon adds AI-based Evaluations for Neurodegenerative Disease and Multiple Sclerosis to Eureka Clinical AI
by TeraRecon, on Apr 27, 2023 3:49:24 PM
Infervision Partnership with ConcertAI's TeraRecon brings their Lung CT.AI to Eureka Clinical AI
by TeraRecon, on Apr 25, 2023 1:08:50 PM
Cercare Medical brings their Neurovascular Clinical Workflows into ConcertAI's TeraRecon Eureka Clinical AI Platform in new Partnership
by TeraRecon, on Apr 24, 2023 2:48:53 PM
ConcertAI's TeraRecon adds AI-based oncology contouring capabilities into the Eureka Clinical AI Platform with Coreline Soft Partnership
by TeraRecon, on Apr 3, 2023 12:22:58 PM
ConcertAI's TeraRecon Brings Osteoarthritis and Fracture Detection to the Eureka Clinical AI Platform with Radiobotics Partnership
by TeraRecon, on April 4, 2023 11:07:33 AM
ConcertAI's TeraRecon and Avicenna.AI Partner on AI for Incidental Pulmonary Embolism
by TeraRecon, on Mar 13, 2023 11:55:04 AM
ConcertAI's TeraRecon Inks Distribution Deals with Seven AI Developers Alongside EU Launch of Eureka Clinical AI Platform at #ECR23
by TeraRecon, on Feb 27, 2023 8:42:30 AM
ConcertAI's TeraRecon, in Us2 AI Partnership, Integrates AI-Enabled Echocardiography Decision Support into Eureka Clinical AI Platform
by TeraRecon, on Feb 24, 2023 9:18:50 AM
ConcertAI's TeraRecon Integrates AI-based Chest Solutions into Eureka Clinical AI Platform through Riverain Technologies Partnership
by TeraRecon, on Feb 23, 2023 12:45:04 PM
ConcertAI's TeraRecon Brings Neuro-oncology Imaging into the Eureka Clinical AI Platform with Imaging Biometrics Partnership
by TeraRecon, on Nov 16, 2022 10:48:39 AM
Interactive
Explore Our
AI Solutions
By Body Region
Click on the body regions to learn more about our AI Partners & Solutions
Imaging Biometrics IB Neuro**
Imaging Biometrics IB Delta T1**
Imaging Biometrics IB Diffusion**
Imaging Biometrics IB DCE**
Cercare Medical MR Neuro Basic*
Cercare Medical MR Neuro Advanced*
Cercare Medical MR Stroke Basic*
Cercare Medical MR Stroke Advanced*
Combinostics cMRI**
*Contracted and going through Technical Integration Testing
**Part of upcoming Neuro Suite
Radiobotics RBknee (US, EU*)
Radiobotics RBfracture (EU)
*Contracted and going through Technical Integration Testing
Imaging Biometrics IB DCE
Imaging Biometrics IB Diffusion
Bot Image ProstatID
Claripi SigMAM*
Coreline Soft LCS
Coreline Soft LCS+ with Emphysema
Coreline Soft LCS+ with CAC
*Contracted and going through Technical Integration Testing
Us2.ai us2v1*
Coreline SoftAVIEW CAC
*Contracted and going through Technical Integration Testing
Infervision InferRead CT Lung
Riverain ClearRead Xray
Riverain ClearRead Xray Pneumothorax*
Riverain ClearRead CT
Riverain ClearRead CT Compare*
Coreline Soft LCS
Coreline Soft LCS+ with Emphysema
Coreline Soft LCS+ with CAC
*Contracted and going through Technical Integration Testing
Get In Touch
Have A
Healthcare
AI App?
Learn how to join the
Eureka AI Partner Program
AI Development Partners
Our Ecosystem of AI Integrations
Provides AI algorithms for MR imaging in various clinical specialties, including brain.
IB Clinic provides imaging insights to help guide decisions by enhancing standard anatomical imaging with key physiological information like true regions of contrast enhancement (void of post-surgical blood products), and tumor blood volume and flow.
Watch the Webinar
Provides AI algorithms that are designed to improve the accuracy and efficiency of chest imaging analysis.
ClearRead applications for CT and X-ray use unique vessel and bone suppression technology that enables radiologists to focus on the actionable data to improve accuracy and quality, while decreasing reading time and the number of missed nodules.
See how 2 doctors used ClearRead CT for lung cancer screening
Provides AI algorithms for the analysis of X-ray images.
RBfracture™ detects fractures in X-rays exams across the entire appendicular skeleton. Additionally, RBknee™ analyzes knee X-rays for osteoarthritis, based on OARSI and KL gradings.
Read the external validation paper
Provides an AI algorithm that aids in the detection of pulmonary nodules through CT scans.
InferRead Lung CT.AI utilizes state-of-the-art deep learning technologies to automatically assist in identifying lung nodules and perform nodule quantifications accurately and efficiently.
Read the advantages of
InferRead Lung CT.AI
Provides thoracic-focused AI algorithms from CT-based imaging processing.
- AVIEW CAC is designed for coronary artery calcium scoring for both gated and non-gated scans.
- AVIEW LCS is designed for lung cancer screening, detecting, and characterizing all different types of nodules.
- AVIEW LCS can be packaged with AVIEW CAC and/or an LAA analysis algorithm to meet your specific needs.
Read the White Paper
Provides maps reflecting oxygen availability, in addition to blood flow and volume for CT and MR imaging.
Cercare Perfusion is a fully-automated, patient-specific perfusion application for brain CT and MRI that provides deep insight into brain tissue oxygenation through standard and unique perfusion biomarkers.
Read how Cercare Perfusion reveals microvascular changes in COVID-19
Provides a software platform that fully automates the analysis and reporting of Transthoracic Echocardiograms.
Us2.AI specializes in Artificial Intelligence and is dedicated to fighting heart disease through the development of deep learning solutions applied to ultrasound medical imaging biomarkers.
Learn how Us2.ai is automating the fight against heart disease
Bot Image™, Inc. is a medical imaging software company that utilizes artificial intelligence technology for magnetic resonance imaging interpretation.
ProstatID™ is a computer-aided diagnosis (CADx) software device used to assist radiologists in the assessment and characterization of prostate abnormalities using MR image data.
Watch how BotImage works
Provides AI-powered products designed to assist clinicians in providing care for patients with neurological disorders.
cMRI goes beyond MRI quantification to provide automated, objective quantification, lesion assessment and biomarker-based diagnostic support for dementia, Multiple Sclerosis, Traumatic Brain Injury and Epilepsy.
Read the Ebook on transforming dementia‑related symptoms
Provides AI solutions for medical imaging, with a focus on improving the efficiency and accuracy of radiology interpretation.
ClariPi's AI solutions, including ClariCT.AI, ClariPulmo, and ClariSIGMAM, aim to dramatically improve the image noise reduction capabilities, the identification of lung abnormalities, and assessment of breast tissue density, respectively.
Read approach to high accuracy breast density estimation in digital mammography.
Provides AI-based technology to assist clinicians to efficiently and accurately diagnose prostate cancer.
Lucida Medical's AI-machine learning software, Pi™, is designed to help radiologists identify prostate cancer lesions from MRI, enabling faster and more accurate prostate cancer detection.
Explore the Patient benefits, Pathway benefits, and Clinical benefits.
Provides AI algorithms tailored for Pulmonary Embolism and both Type A and Type B Aortic Dissection detection in CT Scan.
Avicenna.AI's advanced medical imaging AI solutions identify time-sensitive pathologies in CT scans, enhancing clinicians' workflow.
Optimize management of pulmonary embolism patients.
Provides AI clinical decision-support software that assists in early lung cancer diagnosis and optimal treatment for patients.
Optellum's Virtual Nodule Clinic solution, the first FDA, CE-MDR-cleared, and reimbursable clinical decision support for early-stage lung cancer, assists clinicians in identifying and tracking at-risk patients, and prioritizing those at highest risk for follow-up interventions.
See how Virtual Nodule Clinic improves clinical practice and generates return on investment.
Provides advanced technology applications that help trained medical professionals use medical images more effectively to improve and accelerate cancer care.
MiradaXD, Mirada Medical's innovative multi-modality nuclear medicine imaging software, addresses a range of cancer-related challenges, and supports providers with comprehensive oncology imaging solutions.
Increase your confidence in reading and data interpretation.
FEops HEARTguide™ Improved efficiency and outcomes of LAAO procedures.*
FEops HEARTguide™, cloud-based structural heart procedure planning platform, provides simulation and AI-based anatomical measurements to help make transcatheter structural heart interventions more predictable for physicians.
*PREDICT-LAA , J Am Coll Cardiol Intv. Feb 22, 2023. Epublished DOI: 10.1016/j.jcin.2023.01.008
See FEops HEARTguide™ PreProcedure Planning.
Leverages machine learning algorithms to provide quantitative measurements of all major tissues and structures of the lumbar spine through automatic segmentation.
SmartSoft Healthcare's CoLumbo, an AI driven solution, offers an image post-processing, which is a non-invasive way of analyzing spinal images. It helps radiologists reduce the reading and reporting time, minimizes errors of omission, and brings standardization in reporting practices.
See clinical cases of time savings using CoLumbo.
Offers algorithms facilitating bone fracture identification, pulmonary pathology detection, and Greulich & Pyle bone age assessment.
The groundbreaking BoneView by GLEAMER, certified by CE and FDA, utilizes AI for precise bone fracture identification. Meanwhile, ChestView (CE) aids in spotting pulmonary nodules, and BoneAge evaluates bone maturity.
Reveal the full potential
of imaging with AI.
This partner showcase
is coming soon.
FEops HEARTguide™, cloud-based structural heart procedure planning platform, provides simulation and AI-based anatomical measurements to help make transcatheter structural heart interventions more predictable for physicians.
*PREDICT-LAA , J Am Coll Cardiol Intv. Feb 22, 2023. Epublished DOI: 10.1016/j.jcin.2023.01.008
See FEops HEARTguide™ PreProcedure Planning.
Ready To Start Your Partnership?
Ready To Start Your Partnership?
Click the button below to apply today!
A short description of the amazing things
we are accomplishing together.
Ready To Start Your Partnership?
Click the button below to apply today!
AI Development Partners
Uniquely Positioned To Drive Productivity & Revenue
The leading provider of AI-driven advanced visualization solutions that automate complex clinical worfklows, increase physician efficiency & accelerate time to durable outcomes
AI White Paper
of AI in Medical Imaging
Upcoming Events
April 17
2023 HIMSS Annual
Conference & Exhibition
TeraRecon will be at HIMSS23 in Chicago, Illinois. Save the date!
June 5
2023 UK Imaging &
Oncology Congress
TeraRecon will be exhibiting at UKIO23 in Liverpool, England.
July 31
SNIS 20th Annual Meeting
and Fellows Course
TeraRecon will be exhibiting at SNIS in San Diego, CA.
September 20
46th ESNR Annual
Meeting 2023
TeraRecon will be at the 46th ESNR Annual Meeting in Vienna, Austria.
October 23
TCT 2023
TeraRecon will be at TCT 2023 in San Francisco, California. Save the date!
November 26
RSNA 2023
TeraRecon will be at RSNA 2023 in Chicago, Illinois. Save the date!
Upcoming Events
April 17
2023 HIMSS Annual Conference & Exhibition
TeraRecon will be at HIMSS23 in Chicago, Illinois. Save the date!
June 5
2023 UK Imaging & Oncology Congress
TeraRecon will be exhibiting at UKIO23 in Liverpool, England.
July 31
SNIS 20th Annual Meeting and Fellows Course
TeraRecon will be exhibiting at SNIS in San Diego, CA.
Partner Testimonial
"The tremendous potential for lung cancer screening to reduce mortality in the US is very much unrealized due to a combination of reasons. Based on our experience reviewing the algorithm for the past several months and my observations of its extensive use and testing in Chino, I believe that Infervision's InferRead Lung CT.AI application can serve as a robust lung nodule "spell-checker" with the potential to improve diagnostic accuracy, reduce reading times, and integrate with the image review workflow."
Eliot L. Siegel, MD
Professor and Vice-Chair of Research Information Systems in Radiology, University of Maryland School of Medicine.